Results 181 to 190 of about 412,177 (358)
Increase of Dermatan Sulfate in a Case of Pulmonary Fibrosis
Masakichi Motomiya+5 more
openalex +2 more sources
Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms [PDF]
openalex +1 more source
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley +1 more source
1850 FLOW LIMITATION IN INFANTS WITH CYSTIC FIBROSIS DURING A PULMONARY EXACERBATION [PDF]
Robert S. Tepper+4 more
openalex +1 more source
Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined
Non‐neoplastic diseases pose a significant health burden. Nanozymes, enzyme‐like nanomaterials, offer promising strategies for regulating oxidative stress and inflammation. This review explores their development, structure–function relationships, and therapeutic potential, with a focus on precision medicine through targeted delivery and multimodal ...
Ling Mei+8 more
wiley +1 more source
This work presents a deep learning model to autonomously recognize and classify the secretion retention into three levels for patients receiving invasive mechanical ventilation, achieving 89.08% accuracy. This model can be implemented to ventilators by edge computing, whose feasibility is approved.
Shuai Wang+6 more
wiley +1 more source
A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis. [PDF]
Wang JM+18 more
europepmc +1 more source
INTERSTITIAL PULMONARY FIBROSIS
William B. Ford+3 more
openaire +3 more sources
The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities. [PDF]
Barnes, Teresa R.+16 more
core +2 more sources